Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Rangering i aksjer #39464
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Aksjekurs
$0.11725176
Sist synkronisert: 2025-07-14
Markedsverdi
$481.50K
Endring (1 dag)
-0.20%
Endring (1 år)
0.00%
Land
FR
Handel PHAXIAM Therapeutics S.A. (PHXM)

Kategori

Pris PHXM pris med markedsverdi på B
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
PHXM
$0.11725176
Markedsverdi av PHAXIAM Therapeutics S.A.(PHXM)
Markedsverdi: $481.50K
Per August 2026 har PHAXIAM Therapeutics S.A. en markedsverdi på $481.50K. Dette gjør PHAXIAM Therapeutics S.A. til det 39464th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PHAXIAM Therapeutics S.A. fra 2013 til 2026
PHXM sammenlignet med topp 5 mest populære stocks
Pris på PHXM Eiendel B Markedsverdi for B Resultater
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$1,331,898 $481.50K
$5.470T +1,135,929,987.20%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$1,087,785 $481.50K
$4.467T +927,734,708.21%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$1,016,513 $481.50K
$4.174T +866,949,039.34%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$901,013 $481.50K
$3.700T +768,443,105.15%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$695,067 $481.50K
$2.854T +592,798,392.88%